Department of Clinical pharmacy, Shaoxing Women and Children's Hospital, Shaoxing, Zhejiang, China.
Department of Pharmacy, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
PLoS One. 2020 May 29;15(5):e0227844. doi: 10.1371/journal.pone.0227844. eCollection 2020.
Morroniside is a biologically active polyphenol found in Cornus officinalis Sieb. et Zucc (CO) that exhibits a broad spectrum of pharmacological activities, such as protecting nerves, and preventing diabetic liver damage and renal damage. However, little data are available regarding the mechanism of its intestinal absorption. Here, an in vitro human intestinal epithelial cell model of cultured Caco-2 cells was applied to study the absorption and transport of morroniside. The effects of donor concentration, pH and inhibitors were investigated. The bidirectional permeability of morroniside from the apical (AP) to the basolateral (BL) side and in the reverse direction was studied. When administered at three tested concentrations (5, 25 and 100 μM), the apparent permeability coefficient (Papp) values in the AP-to-BL direction ranged from 1.59 × 10-6 to 2.66 × 10-6 cm/s. In the reverse direction, BL-to-AP, the value was ranged from 2.67 × 10-6 to 4.10 × 10-6 cm/s. The data indicated that morroniside transport was pH-dependent. The permeability of morroniside was affected by treatment with various inhibitors, such as multidrug resistance protein inhibitors MK571 and indomethacin, as well as the breast cancer resistance protein inhibitor apigenin. The mechanisms of the intestinal absorption of morroniside may involve multiple transport pathways, such as the passive diffusion and efflux protein-mediated active transport especially involving multidrug resistance protein 2 and breast cancer resistance protein. After the addition of CO, the Papp values in the AP-to-BL direction increased significantly, therefore, it can be assumed that some ingredients in the CO promote morroniside absorption in the small intestine.
莫诺苷是从山茱萸科植物山茱萸(CO)中分离得到的一种具有生物活性的多酚化合物,具有保护神经、预防糖尿病肝损伤和肾损伤等广泛的药理活性。然而,关于其肠道吸收的机制数据很少。本研究采用体外人肠上皮细胞模型 Caco-2 细胞,研究莫诺苷的吸收和转运。考察了供体浓度、pH 值和抑制剂对其的影响。研究了莫诺苷从顶侧(AP)到基底外侧(BL)侧和相反方向的双向渗透性。在三个测试浓度(5、25 和 100 μM)下,AP 到 BL 方向的表观渗透系数(Papp)值范围为 1.59×10-6 至 2.66×10-6 cm/s。在相反方向 BL 到 AP 时,值范围为 2.67×10-6 至 4.10×10-6 cm/s。数据表明莫诺苷的转运是 pH 依赖性的。莫诺苷的通透性受多种抑制剂的影响,如多药耐药蛋白抑制剂 MK571 和吲哚美辛,以及乳腺癌耐药蛋白抑制剂芹菜素。莫诺苷的肠道吸收机制可能涉及多种转运途径,如被动扩散和外排蛋白介导的主动转运,特别是涉及多药耐药蛋白 2 和乳腺癌耐药蛋白。加入 CO 后,AP 到 BL 方向的 Papp 值显著增加,因此可以假设 CO 中的一些成分促进了莫诺苷在小肠中的吸收。